Biotech

All Articles

TPG leadings up funds to $580M for expenditures all over lifestyle scientific researches

.Property supervisor TPG, which has actually supported biotechs including Sionna Therapies and also ...

Merck stops period 3 TIGIT trial in lung cancer for impossibility

.Merck &amp Co.'s TIGIT course has actually suffered another misfortune. Months after shuttering a s...

After a difficult year, Exscientia folds up right into Recursion

.After a year determined by pipeline hairstyles, the departure of its chief executive officer and al...

Cullinan, after $25M package, hands back bispecific to Harbour

.Cullinan Therapeutics was actually blown away enough along with Port BioMed's bispecific immune act...

A more detailed examine Strong Biotech's Fierce 15

.Within this week's episode of "The Best Pipe," our team are actually diving right into Tough Biotec...

Lilly experiences phase 2 breakdown of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's celebration celebrating the approval of Alzhe...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings and ...

Lykos will definitely inquire FDA to reexamine its own choice observing being rejected of MDMA therapy for post-traumatic stress disorder

.Following an inadequate showing for Lykos Therapeutics' MDMA applicant for post-traumatic stress di...

AN 2 one-halfs headcount, stops stage 3 test after information dissatisfy

.AN2 Rehabs is actually reconsidering its service in action to lackluster midphase information, pled...

Merck spends $700M for bispecific, spying autoimmune opening and odds to challenge Amgen in cancer

.Merck &amp Co. is paying out $700 million in advance to test Amgen in a blood stream cancer market....